Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332972 | 0.85 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL13197625 | 0.85 | TSHR (0.40) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL1010877 | 0.85 | TSHR (0.40) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5069823 | 0.83 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL108692 | 0.83 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL9174637 | 0.82 | TSHR (0.40) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3113881 | 0.82 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL14198618 | 0.82 | TSHR (0.44) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL106615 | 0.81 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL600138 | 0.80 | TSHR (0.50) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120155875-A | Polishing pad for polishing silicon substrate and production process thereof | 东莞市盈鑫半导体材料有限公司 | 2025-06-17 | — | — | CN | claimed |
| WO-2024221838-A1 | POLYMER AND PREPARATION METHOD THEREFOR, GEL POLYMER ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE | 宁德时代新能源科技股份有限公司 | 2024-10-31 | — | — | WO | claimed |
| EP-4035649-B1 | DENTAL ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-07-26 | — | — | EP | claimed |
| CN-115558335-A | Two-component recyclable surface printing delustering oil for BOPP treatment-free surface printing | 浙江浦江永进工贸有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-115401060-A | Method for removing chlorine content in organic hazardous waste | 浙江红狮环保股份有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-115265178-A | Efficient combustion method for sludge combined cement kiln | 浙江红狮环保股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-115067603-A | Sweat-absorbing and deodorizing antibacterial socks and preparation method thereof | 熊玲慧 | 2022-09-20 | — | — | CN | claimed |
| EP-4035649-A1 | DENTAL ADHESIVE COMPOSITION | 3M Innovative Properties Company (US) | 2022-08-03 | — | — | EP | claimed |
| CN-113372485-B | Water-in-oil type nano emulsion, nano emulsion composite response type variable viscosity acid thickener and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-10-29 | — | — | CN | claimed |
| CN-113372485-A | Water-in-oil type nano emulsion, nano emulsion composite response type variable viscosity acid thickener and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-09-10 | — | — | CN | claimed |
| EP-3310792-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-07-21 | — | — | EP | claimed |
| CN-112029088-A | Silane modified polyether based on Michael addition reaction and synthesis method thereof | 郑州大学 | 2020-12-04 | — | — | CN | claimed |
| CN-107743492-B | Process for preparing acryloxysilanes | 美国陶氏有机硅公司 | 2020-07-17 | — | — | CN | claimed |
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | claimed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| US-20010053813-A1 | Rubber compositions | JSR CORPORATION (JP) | 2001-12-20 | — | — | US | claimed |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4622590-A1 | CURABLE COMPOSITION FOR USE IN A PROCESS OF TREATING A DENTAL SITUATION IN THE MOUTH OF A PATIENT | Solventum Intellectual Properties Company (US) | 2025-10-01 | — | — | EP | disclosed |
| US-5247117-A | Neutralization with sterically hindered alcohols or amines, distillation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-09-21 | — | — | US | disclosed |
| EP-0486279-A1 | Process for removing acidic impurities from alkoxysilanes | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | TSHR 4650/4885HPGD 1893/4885ALDH1A1 402/4885 |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SMCHD1, SMC2, SMC1A | TSHR 705/4885HPGD 4304/4885ALDH1A1 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.